Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis: Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment

OBJECTIVE: To investigate the safety of long-term subcutaneous (SC) abatacept treatment using integrated clinical trial data obtained in patients with rheumatoid arthritis refractory to traditional disease-modifying antirheumatic drugs. METHODS: Data from the double-blind and open-label phases of 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Alten, Rieke, Kaine, Jeffrey, Keystone, Edward, Nash, Peter, Delaet, Ingrid, Genovese, Mark C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309516/
https://www.ncbi.nlm.nih.gov/pubmed/24782324
http://dx.doi.org/10.1002/art.38687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309516/
https://www.ncbi.nlm.nih.gov/pubmed/24782324
http://dx.doi.org/10.1002/art.38687

Ejemplares similares